Novavax nod needs a boost

Posted 20 January 2022 PM

After a long, trouble-plagued journey, Novavax's COVID-19 vaccine Nuvaxovid has finally received provisional approval from the TGA - but don't expect a rush on uptake, with the authorisation only for primary vaccination in adults, not boosters.

As of 19 January, over 95 per cent of Australians over the age of 16 had received at least one dose, and 92.7 per cent of Australians over the age of 16 are fully vaccinated, according to the Department of Health. 

To see the whole article, please login